REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 459 filers reported holding REPLIGEN CORP in Q1 2021. The put-call ratio across all filers is 1.51 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2021 | $245,000 | -8.2% | 927 | 0.0% | 0.00% | 0.0% |
| Q3 2021 | $267,000 | +44.3% | 927 | 0.0% | 0.00% | 0.0% |
| Q2 2021 | $185,000 | -27.2% | 927 | -28.9% | 0.00% | 0.0% |
| Q1 2021 | $254,000 | -35.0% | 1,303 | -36.1% | 0.00% | -50.0% |
| Q4 2020 | $391,000 | +5485.7% | 2,040 | +2070.2% | 0.00% | – |
| Q3 2019 | $7,000 | -99.5% | 94 | -99.7% | 0.00% | -100.0% |
| Q2 2015 | $1,296,000 | -92.6% | 31,402 | -94.5% | 0.01% | -92.5% |
| Q1 2015 | $17,423,000 | -7.6% | 573,854 | -39.7% | 0.08% | -4.8% |
| Q4 2014 | $18,849,000 | -20.7% | 951,856 | -20.3% | 0.08% | -27.0% |
| Q3 2014 | $23,782,000 | -17.3% | 1,194,453 | -5.4% | 0.12% | -17.9% |
| Q2 2014 | $28,768,000 | +73.9% | 1,262,271 | -1.9% | 0.14% | +60.9% |
| Q1 2014 | $16,542,000 | -6.6% | 1,286,221 | -0.9% | 0.09% | -12.1% |
| Q4 2013 | $17,708,000 | +23.0% | 1,298,044 | -0.1% | 0.10% | +6.5% |
| Q3 2013 | $14,402,000 | – | 1,298,874 | – | 0.09% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| 12 West Capital Management LP | 1,021,641 | $295,244,000 | 13.47% |
| Ally Bridge Group (NY) LLC | 70,000 | $20,229,000 | 5.95% |
| Miura Global Management | 85,000 | $24,564,000 | 3.81% |
| Conestoga Capital Advisors, LLC | 871,390 | $251,823,000 | 3.48% |
| Ranger Investment Management | 187,723 | $54,250,000 | 2.90% |
| AWM Investment Company, Inc. | 100,000 | $28,899,000 | 2.84% |
| Brown Capital Management | 1,017,477 | $294,041,000 | 2.41% |
| Stephens Investment Management Group LLC | 558,287 | $161,339,000 | 2.19% |
| Yorktown Management & Research Co Inc | 10,050 | $2,904,000 | 2.18% |
| SV Health Investors, LLC | 14,541 | $4,203,000 | 2.06% |